How Health Platforms Monetize Contactless Vitals Features

Revenue in digital health used to come from one place: selling hardware. Blood pressure cuffs, pulse oximeters, wearable bands. The margins were thin, the logistics were painful, and customer acquisition costs ran high because you had to ship something physical before anyone got value. That model is shifting. A growing number of health platforms now monetize contactless vitals features built entirely in software, using the cameras already in patients' phones and laptops. No hardware inventory. No fulfillment chain. Just code.

"Remote patient monitoring reimbursement under CMS grew 128% between 2019 and 2023, with CPT codes 99453-99458 generating an average of $120-$210 per patient per month for qualifying providers." — American Medical Association, RPM Billing Analysis, 2024

Where the money actually comes from

The question of how to monetize contactless vitals health platform features breaks into five distinct revenue channels. Most platforms use two or three simultaneously, which is where the economics get interesting.

The digital health market reached $427 billion in 2025, according to Fortune Business Insights. A meaningful slice of that number flows through platforms that don't manufacture anything. They integrate measurement capabilities through SDKs, build workflows around the data, and charge for access, interpretation, or both. Simon-Kucher's 2024 analysis of provider-side digital health platforms found that platforms adding biometric features to existing services saw 34% higher retention and 2.1x improvement in average revenue per user compared to those offering scheduling and records alone.

Subscription tiers with vitals access

The most straightforward model. Free users get basic features; paid subscribers unlock vital sign scanning. A wellness app might offer mood tracking and journaling for free, then gate heart rate variability, respiratory rate, and stress scoring behind a $9.99/month tier. The measurement itself costs almost nothing to deliver once the SDK is integrated, so the gross margin on vitals-enabled tiers runs between 85-92%.

Dr. Shwetak Patel at the University of Washington, whose lab has published extensively on phone-based physiological sensing, noted in a 2024 IEEE Pervasive Computing paper that camera-based vitals measurement has near-zero marginal cost per scan. The infrastructure cost is in the initial model training and validation. Once deployed, each additional user scan consumes only compute cycles on the device itself, not on the platform's servers.

CMS reimbursement through RPM billing codes

This is where the real money sits for clinical platforms. CMS reimburses remote patient monitoring under CPT codes 99453 through 99458. A provider organization monitoring a patient's vitals remotely can bill roughly $120-$210 per patient per month, depending on the time documented and services rendered. Contactless vitals collected through a phone camera qualify for these codes when the data flows into a clinical record and a provider reviews it.

A 2025 analysis from Definitive Healthcare found that RPM claims grew 47% year-over-year, with cardiology and pulmonology accounting for the largest share. The platforms facilitating this billing take a percentage or charge a per-patient SaaS fee. Either way, the unit economics work because the measurement infrastructure is software, not shipped devices.

As we covered in our telehealth platform integration guide, the clinical workflow is what creates reimbursable events. The vitals capture is the enabling layer.

Revenue model	Typical revenue per user/month	Gross margin	Best fit	Scalability
Consumer subscription	$5-$15	85-92%	Wellness apps, fitness platforms	High — no hardware logistics
RPM/CMS billing	$120-$210	60-75%	Clinical platforms, health systems	Medium — requires provider oversight
Insurance carrier licensing	$0.50-$3 per assessment	90%+	Insurtech, underwriting platforms	Very high — volume-driven
B2B SDK licensing	$10K-$100K+ annually	70-85%	Platform companies, OEMs	High — recurring contracts
Data insights (anonymized)	$2-$8 per user/year	80%+	Research partnerships, pharma	Medium — requires scale and consent

Insurance carrier integrations

Life insurance carriers pay for health assessments during underwriting. A contactless vital signs scan that replaces or supplements a paramedical exam has direct dollar value. The carrier avoids the $100-$300 cost of sending a nurse, the applicant gets a faster experience, and the platform processing the scan charges per assessment.

This model works on volume. A carrier processing 500,000 applications per year might run 200,000 through a contactless screening. Even at $1.50 per scan, that's $300,000 in annual revenue from a single client. The platform's cost to deliver each scan is negligible.

B2B SDK and API licensing

Some platforms don't sell to end users at all. They license the measurement capability to other companies. A telehealth vendor wants vitals in their video visits. A corporate wellness company wants biometric screening without onsite nurses. A senior care platform wants daily check-ins without mailing wearables to 80-year-olds.

The licensing model varies: flat annual fees, per-scan pricing, or revenue sharing. What stays consistent is the margin structure. The SDK provider builds the measurement engine once and licenses it many times. Dr. Daniel McDuff, who led camera-based physiological sensing research at Microsoft Research before joining Google, has written about how pre-trained rPPG models can generalize across diverse populations when properly validated. That generalizability is what makes the licensing model work. One engine, many deployments.

Anonymized health insights

The fifth channel is the most sensitive and the most regulated, but it exists. Platforms with large user bases generating daily vitals data can package anonymized, aggregated insights for pharmaceutical companies, public health researchers, and population health organizations. A dataset showing respiratory rate trends across 50,000 users during flu season has research value.

This only works with explicit user consent, proper de-identification, and compliance with HIPAA, GDPR, or whatever regulatory framework applies. The platforms that do it well treat it as a secondary revenue stream layered on top of their primary model, not as the main business.

How the unit economics break down by platform type

Not every monetization channel fits every platform. The math depends on who your users are and what relationship you have with payers.

Clinical platforms targeting health systems

Health systems care about reimbursement. A platform that helps a cardiology practice monitor 500 heart failure patients remotely can generate $60,000-$105,000 per month in RPM billing. The platform takes a SaaS fee of $15-$40 per patient per month, leaving the practice with meaningful margin after provider time is accounted for.

The 2024 KLAS Research report on RPM platforms found that practices achieving positive ROI on remote monitoring did so within 4-6 months of deployment. The ones that struggled typically had poor patient enrollment workflows, not economics problems with the monitoring itself.

Consumer wellness apps

Consumer apps live and die on conversion rates. If 5% of free users convert to a paid tier and the tier costs $9.99/month, you need 200,000 free users to generate $100,000 in monthly recurring revenue. That's a viable business, but customer acquisition in consumer health is expensive. IQVIA's 2024 Digital Health Trends report noted that the average health app loses 80% of users within three months.

Contactless vitals features help with retention. A daily 30-second face scan creates a lightweight habit loop that gives users a reason to open the app. Platforms that added vitals scanning to existing wellness apps saw engagement metrics improve, which improves conversion, which improves revenue. It's a flywheel, though it takes time to spin up.

Corporate wellness and employer health

Employers spend an average of $1,200-$1,800 per employee per year on wellness programs, according to the National Business Group on Health's 2024 employer survey. Biometric screening is a standard component. Replacing in-person screening events with phone-based contactless vitals scanning cuts the per-employee cost dramatically while increasing participation rates. Employees who skip the onsite blood draw will do a 30-second phone scan from their desk.

The platform revenue here is B2B contract-based: annual fees per employee, often bundled with coaching, analytics, and reporting. Margins are strong because delivery is fully digital.

What determines which model wins

The monetization strategy that works best depends on three things: who pays, what data flows where, and how much clinical weight the measurement carries.

If the payer is CMS, you need clinical-grade data flowing into an EHR with provider review. That means FHIR compatibility, clinical validation studies, and a workflow that generates billable events. The revenue ceiling is high but so is the implementation complexity.

If the payer is a consumer, you need retention. The measurement has to feel valuable enough to justify a monthly charge. Trend analysis, coaching, and health scores built on top of raw vitals numbers are what create that perceived value.

If the payer is an enterprise buyer, you need integration flexibility. Every corporate wellness program, insurance carrier, and telehealth vendor has different technical requirements. API-first architecture matters more than any single feature.

Current research and market evidence

The academic literature supports the economic viability of camera-based vitals in commercial settings. A 2025 study in NPJ Digital Medicine by researchers at MIT and Massachusetts General Hospital found that smartphone-based physiological measurement achieved sufficient accuracy for screening-level applications in a study of 1,200 participants across varied skin tones and lighting conditions. Screening-level accuracy is the threshold that matters for most monetization models. You don't need ICU-grade precision to power a wellness subscription or an insurance screening.

Rock Health's 2025 year-end funding report showed that U.S. digital health venture investment reached $14.2 billion, with remote monitoring and virtual care capturing the largest share of growth-stage funding. The report specifically called out "camera-based measurement" as an emerging category within remote monitoring, distinct from traditional wearable-dependent RPM.

On the regulatory side, the FDA's 2024 guidance on clinical decision support software clarified that many vitals-adjacent features fall outside device classification when used for wellness rather than diagnosis. That distinction matters for monetization because wellness-classified features have faster go-to-market timelines and lower compliance costs than regulated medical devices.

What the next two years probably look like

Three trends will shape how health platforms monetize contactless vitals between now and 2028.

First, CMS reimbursement codes for remote monitoring will likely expand. CMS has added new RPM codes in each of the last three annual updates, and the agency's stated direction favors hospital-at-home and virtual care models that depend on remote measurement.

Second, insurance carriers will move from pilot programs to production deployments. The life insurance industry tested contactless vitals for underwriting through 2024 and 2025. The carriers that saw improved completion rates and reduced underwriting cycle times will scale those programs. That means more volume flowing through platforms built on camera-based SDKs.

Third, the consumer tier model will consolidate. The market can't support hundreds of wellness apps all charging $9.99/month for vitals scanning. The platforms that combine measurement with meaningful interpretation, coaching, and longitudinal tracking will absorb the ones selling raw numbers.

Frequently asked questions

Can contactless vitals features generate enough revenue to sustain a platform?

Yes, depending on the model. Clinical platforms billing CMS for RPM can generate $120-$210 per patient per month. Consumer apps need scale but have strong margins once they reach it. The key is choosing a monetization channel that matches your user base and payer relationship.

Do insurance carriers actually pay for contactless health assessments?

Several carriers are in production or advanced pilots for contactless underwriting assessments. The value proposition is clear: faster application completion, lower cost per assessment, and better applicant experience compared to scheduling a nurse visit. Per-assessment pricing typically runs $0.50-$3.00.

What compliance requirements affect monetization?

It depends on the claim you're making. Wellness features used for general health awareness have lighter regulatory requirements than diagnostic tools. RPM billing requires clinical-grade data handling, HIPAA compliance, and documented provider review. Insurance applications need to meet state regulatory requirements for underwriting data. The monetization model you choose determines which compliance framework applies.

How long does it take to see ROI on adding contactless vitals?

For B2B integrations with existing revenue, ROI typically appears within one to two quarters as the feature improves retention and enables upselling. For new consumer products, the timeline depends on user acquisition costs and conversion rates. KLAS Research found clinical RPM platforms reach positive ROI within 4-6 months when enrollment workflows are well-designed.

Building a monetization engine around contactless vitals is less about the measurement technology and more about the business layer on top of it. Platforms like Circadify provide the SDK and API infrastructure that handles the hard part, the signal processing, the model accuracy, the cross-platform support, so that product teams can focus on the revenue model that fits their market.